Article Details

Read Original
Tokenist

Cogent Biosciences Stock Soars 120% on Positive Phase 3 Cancer Drug Results

Cogent Biosciences stock jumped 120% after positive Phase 3 PEAK trial results for its GIST drug bezuclastinib.The post Cogent Biosciences Stock Soars 120% on Positive Phase 3 Cancer Drug Results appeared first on Tokenist.

0 |
0
🐂
—
🐻

Article URL

https://tokenist.com/cogent-biosciences-stock-soars-120-on-positive-phase-3-cancer-drug-results/?utm_source=rss&utm_medium=rss&utm_campaign=cogent-biosciences-stock-soars-120-on-positive-phase-3-cancer-drug-results

Latest Crypto Articles

Community-submitted articles and insights

View all

Fear & Greed Index

Market sentiment indicator (24h)

62
Index
Greed
Extreme Fear Neutral Extreme Greed
0 50 100

Trending Coins Index

BTC
64 Greed
XRP
63 Greed
ETH
63 Greed
TRUMP
60 Greed
NEAR
60 Greed
View All Coins

Updated 8m ago

Trending Topics

Last 6h
View Full Word Cloud

Top Sources

1
Coinpaprika
98
2
Cryptopolitan
62
3
Cointelegraph
56
View All Sources

Trending Coins

1
Bitcoin BTC
294
2
XRP XRP
82
3
Ethereum ETH
77
View All Coins

Latest Crypto News

Real-time updates from trusted sources

Loading more news...